Down-regulation of orexin gene expression by severe obesity in the rats: studies in Zucker fatty and Zucker diabetic fatty rats and effects of rosiglitazone
- 1 April 2000
- journal article
- Published by Elsevier in Molecular Brain Research
- Vol. 77 (1), 131-137
- https://doi.org/10.1016/s0169-328x(00)00041-3
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Differential distribution of orexin-A and orexin-B immunoreactivity in the rat brain and spinal cord☆Peptides, 1999
- Hypothalamic orexin expression: modulation by blood glucose and feeding.Diabetes, 1999
- Narcolepsy in orexin Knockout MiceCell, 1999
- The effect of the orexins on food intake: comparison with neuropeptide Y, melanin-concentrating hormone and galaninJournal of Endocrinology, 1999
- Thiazolidinediones: a new class of antidiabetic drugsDiabetic Medicine, 1999
- Orexins, orexigenic hypothalamic peptides, interact with autonomic, neuroendocrine and neuroregulatory systemsProceedings of the National Academy of Sciences, 1999
- RosiglitazoneDrugs, 1999
- The hypocretins: Hypothalamus-specific peptides with neuroexcitatory activityProceedings of the National Academy of Sciences, 1998
- Activators of peroxisome proliferator-activated receptor gamma have depot-specific effects on human preadipocyte differentiation.JCI Insight, 1997
- Phenotypes of Mouse diabetes and Rat fatty Due to Mutations in the OB (Leptin) ReceptorScience, 1996